Global investments in TB control: Economic benefits

Ramanan Laxminarayan, Eili Klein, Sarah Darley, Olusoji Adeyi

Research output: Contribution to journalArticle

Abstract

The Global Plan to Stop TB calls for significant financial resources to meet the Millennium Development Goals for tuberculosis. However, it is unclear whether the economic benefits of TB control exceed the costs. Using an epidemiological model, we find that the economic benefits of the Global Plan relative to sustained DOTS (a commonly used treatment method) were unambiguously greater than the incremental costs in all nine high-burden countries in Africa and in Afghanistan, Pakistan, and Russia. Benefit-cost ratios of sustaining DOTS at current levels relative to having no DOTS exceeded 1 in all twenty-two high-burden, TB-endemic countries and sub-Saharan Africa.

Original languageEnglish (US)
JournalHealth Affairs
Volume28
Issue number4
DOIs
StatePublished - Jul 2009
Externally publishedYes

Fingerprint

Economic Models
Afghanistan
Cost Control
Africa South of the Sahara
Russia
Pakistan
Cost-Benefit Analysis
Tuberculosis
Economics
Costs and Cost Analysis

ASJC Scopus subject areas

  • Health Policy

Cite this

Global investments in TB control : Economic benefits. / Laxminarayan, Ramanan; Klein, Eili; Darley, Sarah; Adeyi, Olusoji.

In: Health Affairs, Vol. 28, No. 4, 07.2009.

Research output: Contribution to journalArticle

Laxminarayan, Ramanan ; Klein, Eili ; Darley, Sarah ; Adeyi, Olusoji. / Global investments in TB control : Economic benefits. In: Health Affairs. 2009 ; Vol. 28, No. 4.
@article{2ca4ee4437504c849a8b1cb5a20901c9,
title = "Global investments in TB control: Economic benefits",
abstract = "The Global Plan to Stop TB calls for significant financial resources to meet the Millennium Development Goals for tuberculosis. However, it is unclear whether the economic benefits of TB control exceed the costs. Using an epidemiological model, we find that the economic benefits of the Global Plan relative to sustained DOTS (a commonly used treatment method) were unambiguously greater than the incremental costs in all nine high-burden countries in Africa and in Afghanistan, Pakistan, and Russia. Benefit-cost ratios of sustaining DOTS at current levels relative to having no DOTS exceeded 1 in all twenty-two high-burden, TB-endemic countries and sub-Saharan Africa.",
author = "Ramanan Laxminarayan and Eili Klein and Sarah Darley and Olusoji Adeyi",
year = "2009",
month = "7",
doi = "10.1377/hlthaff.28.4.w730",
language = "English (US)",
volume = "28",
journal = "Health Affairs",
issn = "0278-2715",
publisher = "Project Hope",
number = "4",

}

TY - JOUR

T1 - Global investments in TB control

T2 - Economic benefits

AU - Laxminarayan, Ramanan

AU - Klein, Eili

AU - Darley, Sarah

AU - Adeyi, Olusoji

PY - 2009/7

Y1 - 2009/7

N2 - The Global Plan to Stop TB calls for significant financial resources to meet the Millennium Development Goals for tuberculosis. However, it is unclear whether the economic benefits of TB control exceed the costs. Using an epidemiological model, we find that the economic benefits of the Global Plan relative to sustained DOTS (a commonly used treatment method) were unambiguously greater than the incremental costs in all nine high-burden countries in Africa and in Afghanistan, Pakistan, and Russia. Benefit-cost ratios of sustaining DOTS at current levels relative to having no DOTS exceeded 1 in all twenty-two high-burden, TB-endemic countries and sub-Saharan Africa.

AB - The Global Plan to Stop TB calls for significant financial resources to meet the Millennium Development Goals for tuberculosis. However, it is unclear whether the economic benefits of TB control exceed the costs. Using an epidemiological model, we find that the economic benefits of the Global Plan relative to sustained DOTS (a commonly used treatment method) were unambiguously greater than the incremental costs in all nine high-burden countries in Africa and in Afghanistan, Pakistan, and Russia. Benefit-cost ratios of sustaining DOTS at current levels relative to having no DOTS exceeded 1 in all twenty-two high-burden, TB-endemic countries and sub-Saharan Africa.

UR - http://www.scopus.com/inward/record.url?scp=67651211502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651211502&partnerID=8YFLogxK

U2 - 10.1377/hlthaff.28.4.w730

DO - 10.1377/hlthaff.28.4.w730

M3 - Article

C2 - 19567413

AN - SCOPUS:67651211502

VL - 28

JO - Health Affairs

JF - Health Affairs

SN - 0278-2715

IS - 4

ER -